Susanne Hartmann

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Amgen Inc., U3 Pharma Gmbh, Daiichi Sankyo Europe Gmbh. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanne Hartmann. Retrieved from https://idiyas.com/inventor/susanne-hartmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 49(Granted Patents)

Location History:

München, DE (2010 - 2016)
Munich, DE (2018 - 2022)

Company Filing History:

Daiichi Sankyo Europe Gmbh

patents

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11267900 - Antibodies directed to HER-3 and uses thereof (2022-03-08),

2. 10100124 - Antibodies directed to HER-3 and uses thereof (2018-10-16),

3. 9249230 - Antibodies directed to HER-3 and uses thereof (2016-02-02),

4. 8771695 - Antibodies directed to HER-3 and uses thereof (2014-07-08),

5. 7705130 - Antibodies directed to HER-3 and uses thereof (2010-04-27),

Title: The Inventive Journey of Susanne Hartmann: Pioneering Solutions in Medicine

Introduction: Susanne Hartmann, a distinguished inventor hailing from Munich, Germany, has made significant contributions in the field of medicine with his innovative patents and groundbreaking research.

Latest Patents: Susanne Hartmann holds 5 patents, with his latest inventions focusing on antibodies directed to HER-3 and their various applications in diagnosing and treating diseases associated with HER-3 mediated signal transduction and heregulin. These patents encompass binding proteins, polynucleotides, expression vectors, and methodologies crucial for combating ailments linked to HER-3.

Career Highlights: Throughout his career, Susanne Hartmann has showcased exceptional expertise in his field. He has notably worked with renowned companies such as Amgen Inc. and U3 Pharma GmbH, where his inventive spirit and dedication to advancing medical solutions have been instrumental in shaping the industry.

Collaborations: Collaborating with talented individuals is a cornerstone of Susanne Hartmann's success. Among his notable coworkers are Mike Rothe and Martin Treder, whose combined efforts have led to the development of impactful technologies and treatments in the realm of HER-3 related disorders.

Conclusion: Susanne Hartmann's relentless pursuit of innovation and his remarkable patent portfolio underscore his commitment to revolutionizing healthcare. His pioneering work not only reflects his exceptional skills as an inventor but also his unwavering dedication to improving the lives of many through cutting-edge medical advancements.

Profile summary based on public USPTO records.